{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:22:09Z","timestamp":1775082129173,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jpurol.2019.05.028","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T11:22:39Z","timestamp":1559733759000},"page":"552.e1-552.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy of electromotive drug administration in delivering botulinum toxin a in children with neuropathic detrusor overactivity\u2014outcomes of a pilot study"],"prefix":"10.1016","volume":"15","author":[{"given":"C.","family":"Koh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5647-4094","authenticated-orcid":false,"given":"C.V.","family":"Melling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2019.05.028_bib1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.eururo.2005.12.056","article-title":"Early start to therapy preserves kidney function in spina bifida patients","volume":"49","author":"Dik","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib2","first-page":"840","article-title":"The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration","volume":"146","author":"Kasabian","year":"1992","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jpurol.2019.05.028_bib3","first-page":"198","article-title":"Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art","volume":"8","author":"Nitti","year":"2006","journal-title":"Rev Urol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jpurol.2016.01.002","article-title":"British Association of Paediatric Urologists consensus statement on the management of the neuropathic bladder","volume":"12","author":"Lee","year":"2016","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jpurol.2013.10.011","article-title":"Single-center experience with botulinum toxin endoscopic detrusor injection for the treatment of congenital neuropathic bladder in children: effect of dose adjustment, multiple injections, and avoidance of reconstructive procedures","volume":"10","author":"Figueroa","year":"2014","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib6","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.juro.2007.08.032","article-title":"Botulinum-a toxin: solo treatment for neuropathic noncompliant bladder","volume":"178","author":"Neel","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","article-title":"Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia","volume":"171","author":"Riccabona","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.urology.2006.05.056","article-title":"Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele","volume":"68","author":"Kajbafzadeh","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2019.05.028_bib9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.2007.06977.x","article-title":"Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction","volume":"100","author":"Akbar","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2019.05.028_bib10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.eururo.2006.08.025","article-title":"New frontiers in intravesical therapies and drug\u00a0delivery","volume":"50","author":"Giannantoni","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1464-410X.1997.32419.x","article-title":"Bladder and urethral anaesthesia with electromotive drug administration (EMDA): a technique for invasive endoscopic procedure","volume":"79","author":"Fontanella","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2019.05.028_bib12","first-page":"875","article-title":"Electromotive delivery of mitomycin C into human bladder wall","volume":"57","author":"Di Stasi","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpurol.2019.05.028_bib13","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2309","article-title":"Investigation of the mechanisms of action behind electromotive drug administration (EMDA)","volume":"4","author":"Kos","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.jpurol.2019.05.028_bib14","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.urology.2010.09.036","article-title":"Intravesical electromotive botulinum toxin type A administration: Part I - experimental study","volume":"77","author":"Kajbafzadeh","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2019.05.028_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.urology.2010.06.003","article-title":"Intravesical electromotive botulinum toxin type A administration\u2014Part II: clinical application","volume":"77","author":"Kajbafzadeh","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2019.05.028_bib16","series-title":"Overactive bladder, nocturnal enuresis and giggle incontinence guidelines (Children)","author":"Goyal","year":"2017"},{"key":"10.1016\/j.jpurol.2019.05.028_bib17","series-title":"Physion\u00ae. Pediatric OAB\/Hyperspastic bladder","year":"2011"},{"key":"10.1016\/j.jpurol.2019.05.028_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2006.01438.x","article-title":"Pharmacology of botulinum toxin: differences between type A preparations","volume":"13","author":"Rosales","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib19","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/nau.22783","article-title":"International Children's Continence Society standardization report on urodynamic studies of the lower urinary tract in children","volume":"34","author":"Bauer","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2019.05.028_bib20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00384-016-2514-9","article-title":"Intravesical electromotive botulinum toxin type A administration for management of concomitant neuropathic bowel and bladder dysfunction in children","volume":"31","author":"Kajbafzadeh","year":"2016","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.jpurol.2019.05.028_bib21","first-page":"4","article-title":"Intravesical electromotive botulinum toxin in women with overactive bladder \u2013 a pilot\u00a0study","volume":"2","author":"Schiotz","year":"2017","journal-title":"ARC J Gynecol Obstet"},{"key":"10.1016\/j.jpurol.2019.05.028_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.urology.2017.11.039","article-title":"Intravesical electromotive botulinum toxin type \u201cA\u201d administration for\u00a0management of urinary incontinence secondary to neuropathic detrusor overactivity in children: long-term follow-up","volume":"114","author":"Ladi-Seyedian","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2019.05.028_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.sc.3101593","article-title":"Electromotive drug administration of lidocaine to anesthetize the bladder before botulinum-A toxin injections into the detrusor","volume":"42","author":"Schurch","year":"2004","journal-title":"Spinal Cord"},{"key":"10.1016\/j.jpurol.2019.05.028_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00005392-199707000-00076","article-title":"Electromotive administration of oxybutynin into the human bladder wall","volume":"158","author":"Di Stasi","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00005392-200102000-00032","article-title":"Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens","volume":"165","author":"Di Stasi","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1470-2045(11)70190-5","article-title":"Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non? muscle invasive bladder cancer: a randomised controlled trial","volume":"12","author":"Di Stasi","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40268-014-0077-1","article-title":"Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products","volume":"15","author":"Frevert","year":"2015","journal-title":"Drugs R"},{"key":"10.1016\/j.jpurol.2019.05.028_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2147\/BTT.S65603","article-title":"Botulinum toxin type A products are not interchangeable: a review of the evidence","volume":"8","author":"Brin","year":"2014","journal-title":"Biol Targets Ther"},{"key":"10.1016\/j.jpurol.2019.05.028_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.toxicon.2010.12.019","article-title":"Studies on the dissociation of botulinum neurotoxin type A complexes","volume":"57","author":"Eisele","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.jpurol.2019.05.028_bib30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/nau.20914","article-title":"Is the Urothelium Intelligent?","volume":"29","author":"Birder","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2019.05.028_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.sc.3101565","article-title":"Bladder epithelium is abnormal in patients with neurogenic bladder due to myelomeningocele","volume":"42","author":"Schlager","year":"2004","journal-title":"Spinal Cord"},{"key":"10.1016\/j.jpurol.2019.05.028_bib32","doi-asserted-by":"crossref","DOI":"10.1590\/S1677-55382011000600031","article-title":"Effects of botulinum toxin type a in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections","volume":"37","author":"Pascali","year":"2011","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib33","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0022-5347(17)38521-X","article-title":"Bladder wall abnormalities in myelodysplastic bladders: a computer assisted morphometric analysis","volume":"145","author":"Shapiro","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2019.05.028_bib34","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","article-title":"Histologic features in the urinary bladder wall affected from neurogenic overactivity-A comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A","volume":"50","author":"Comp\u00e9rat","year":"2006","journal-title":"Eur Urol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513119301482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513119301482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:46:04Z","timestamp":1761486364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513119301482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1477513119301482"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2019.05.028","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of electromotive drug administration in delivering botulinum toxin a in children with neuropathic detrusor overactivity\u2014outcomes of a pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2019.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Ltd on behalf of Journal of Pediatric Urology Company. All rights reserved.","name":"copyright","label":"Copyright"}]}}